Akihisa Imagawa Selected Research

src kinase associated phosphoprotein 2

4/2022

Research following genome-wide association study focuses on the multifaceted nature of Src kinase-associated phosphoprotein 2 in type 1 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akihisa Imagawa Research Topics

Disease

41	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2022 - 09/2002
22	Type 2 Diabetes Mellitus (MODY) 01/2021 - 04/2006
10	Hyperglycemia 05/2018 - 01/2002
9	Insulin Resistance 01/2018 - 12/2010
6	Neoplasms (Cancer) 01/2022 - 10/2003
6	Ketosis 01/2022 - 01/2007
5	Disease Progression 01/2019 - 02/2008
5	Glucose Intolerance 11/2018 - 06/2012
4	Hypoglycemia (Reactive Hypoglycemia) 06/2017 - 01/2012
4	Hypersensitivity (Allergy) 01/2017 - 02/2008
3	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2022 - 01/2008
3	Hypertension (High Blood Pressure) 01/2018 - 06/2011
3	Weight Loss (Weight Reduction) 09/2015 - 09/2012
3	Virus Diseases (Viral Diseases) 01/2015 - 01/2006
3	Insulinoma 01/2015 - 03/2010
3	Obesity 09/2012 - 12/2011
2	Cushing Syndrome 01/2022 - 10/2003
2	Hyperaldosteronism (Conn Syndrome) 01/2022 - 12/2009
2	Diabetes Mellitus 01/2021 - 01/2016
2	Body Weight (Weight, Body) 10/2020 - 09/2012
2	Diabetic Neuropathies (Diabetic Neuropathy) 04/2019 - 02/2008
2	Arteriosclerosis 07/2018 - 01/2015
2	Dyslipidemias (Dyslipidemia) 01/2018 - 06/2011
2	Hyperinsulinism (Hyperinsulinemia) 11/2017 - 01/2015
2	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2014 - 01/2012
2	Hyperuricemia 11/2011 - 06/2011
2	Graves Disease (Basedow Disease) 06/2009 - 07/2004
2	Thyroiditis 01/2007 - 07/2004
2	Mason-Type Diabetes 04/2002 - 01/2002
1	Adrenocortical Adenoma (Disease, Conn's) 01/2022
1	Diabetes Complications 01/2022
1	Polyuria 01/2022
1	Polydipsia 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021
1	Albuminuria 10/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 10/2020
1	Multiple Myeloma 01/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2020
1	Myocarditis (Carditis) 01/2020
1	Hemorrhage 07/2018
1	Diabetic Retinopathy (Retinopathy, Diabetic) 07/2018
1	Vitreous Hemorrhage 07/2018
1	Muscle Cramp (Cramp) 05/2018
1	Pain (Aches) 05/2018
1	Diabetic Angiopathies (Diabetic Angiopathy) 05/2018
1	Donohue Syndrome 11/2017

Drug/Important Bio-Agent (IBA)

26	Insulin (Novolin)FDA Link 01/2022 - 01/2008
16	Glucose (Dextrose)FDA LinkGeneric 11/2018 - 01/2002
11	AutoantibodiesIBA 01/2022 - 08/2003
7	Blood Glucose (Blood Sugar)IBA 10/2020 - 01/2008
6	Hemoglobins (Hemoglobin)IBA 01/2018 - 03/2010
5	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2019
5	EnzymesIBA 10/2018 - 01/2007
5	C-PeptideIBA 08/2017 - 01/2007
5	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2015 - 01/2007
4	Glucagon (Glukagon)FDA Link 01/2019 - 01/2012
4	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 08/2017 - 03/2010
3	CytokinesIBA 10/2020 - 01/2017
3	Hydrocortisone (Cortisol)FDA LinkGeneric 04/2019 - 10/2003
3	InterferonsIBA 08/2017 - 11/2004
3	Hormones (Hormone)IBA 01/2017 - 01/2012
3	Biomarkers (Surrogate Marker)IBA 01/2016 - 12/2011
3	Exenatide (Byetta)FDA Link 01/2015 - 01/2011
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2015 - 12/2011
3	AlbuminsIBA 01/2013 - 12/2010
3	Liraglutide FDA Link 09/2012 - 12/2011
3	HLA-DR Antigens (HLA-DR)IBA 11/2011 - 11/2008
2	LigandsIBA 10/2020 - 01/2010
2	AntigensIBA 10/2020 - 03/2008
2	Insulin ReceptorIBA 11/2017 - 01/2015
2	RNA (Ribonucleic Acid)IBA 08/2017 - 11/2011
2	Pharmaceutical PreparationsIBA 01/2017 - 12/2012
2	AdiponectinIBA 01/2015 - 09/2002
2	Transaminases (Aminotransferases)IBA 06/2014 - 01/2008
2	HLA Antigens (Human Leukocyte Antigens)IBA 12/2012 - 01/2006
2	AntibodiesIBA 02/2012 - 08/2003
1	src kinase associated phosphoprotein 2IBA 04/2022
1	Cytochrome P450 Family 11IBA 01/2022
1	Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 10/2021
1	ErbB Receptors (EGF Receptor)IBA 10/2021
1	LinagliptinIBA 01/2021
1	Angiotensin IIIBA 10/2020
1	Chymases (Chymase)IBA 10/2020
1	Bortezomib (Velcade)FDA Link 01/2020
1	Cardiac MyosinsIBA 01/2020
1	Glucagon-Like Peptide-1 ReceptorIBA 04/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2019
1	CholesterolIBA 07/2018
1	LDL CholesterolIBA 07/2018
1	Triglycerides (Triacylglycerol)IBA 07/2018
1	LDL Lipoproteins (beta Lipoproteins)IBA 07/2018
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 07/2018
1	Antihypertensive Agents (Antihypertensives)IBA 07/2018
1	Carnitine (L-Carnitine)FDA LinkGeneric 05/2018
1	erucylphosphocholineIBA 05/2018

Therapy/Procedure

14	Therapeutics 10/2020 - 11/2004
12	Glycemic Control 01/2022 - 02/2008
1	Vitrectomy 07/2018
1	Pancreatectomy 01/2018